Related references
Note: Only part of the references are listed.The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer
Luke Pardy et al.
PROSTATE (2020)
Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract
Satoshi Inoue et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Asparaginyl endopeptidase enhances pancreatic ductal adenocarcinoma cell invasion in an exosome-dependent manner and correlates with poor prognosis
Qiang Yan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease
Zhi-Hao Wang et al.
NATURE COMMUNICATIONS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Targeting Legumain As a Novel Therapeutic Strategy in Cancers
Chun-Wai Mai et al.
CURRENT DRUG TARGETS (2017)
Asparaginyl endopeptidase promotes proliferation and invasiveness of prostate cancer cells via PI3K/AKT signaling pathway
Wenjing Zhu et al.
GENE (2016)
Silodosin Inhibits Prostate Cancer Cell Growth Via ELK1 Inactivation and Enhances the Cytotoxic Activity of Gemcitabine
Takashi Kawahara et al.
PROSTATE (2016)
Viro-immune therapy: A new strategy for treatment of pancreatic cancer
Andrea Marie Ibrahim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer
Laura E. Edgington-Mitchell et al.
ONCOTARGET (2015)
Clinicopathologic significance of legumain overexpression in cancer: a systematic review and meta-analysis
Ye Zhen et al.
SCIENTIFIC REPORTS (2015)
Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis
S. Jagadeeshan et al.
ONCOGENE (2015)
Chemoradiation Therapy Sequencing for Resected Pancreatic Adenocarcinoma in the National Cancer Data Base
Lauren E. Colbert et al.
CANCER (2014)
Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma
Amal H. I. Al Haddad et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Pericellular proteolysis in cancer
Lisa Sevenich et al.
GENES & DEVELOPMENT (2014)
Pancreatic tumour formation and recurrence after radiotherapy are blocked by targeting CD44
Natalie J. Wood
Nature Reviews Gastroenterology & Hepatology (2014)
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities
Zenobia C. D'Costa et al.
ONCOTARGET (2014)
Transcriptional regulation of the legumain gene by p53 in HCT116 cells
Takuya Yamane et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Nuclear Legumain Activity in Colorectal Cancer
Mads H. Haugen et al.
PLOS ONE (2013)
Asparaginyl endopeptidase cleaves TDP-43 in brain
Jeremy H. Herskowitz et al.
PROTEOMICS (2012)
Asparagine endopeptidase is required for normal kidney physiology and homeostasis
Gail Miller et al.
FASEB JOURNAL (2011)
Toll-like Receptor 9: AEP Takes Control
Peter van Endert
IMMUNITY (2009)
COBRA1 inhibits AP-1 transcriptional activity in transfected cells
HJ Zhong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)